featured
Single-Inhaler Triple Therapy vs Inhaled Corticosteroid Plus Long-Acting β2-Agonist Therapy for COPD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Single Inhaler Triple Therapy Versus Inhaled Corticosteroid Plus Long-Acting β2-Agonist Therapy for Chronic Obstructive Pulmonary Disease (TRILOGY): A Double-Blind, Parallel Group, Randomised Controlled Trial
Lancet 2016 Sep 03;388(10048)963-973, D Singh, A Papi, M Corradi, I Pavlišová, I Montagna, C Francisco, G Cohuet, S Vezzoli, M Scuri, J VestboFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.